Atlas Trials

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Clinical trial NCT02818725 · COMPLETED

Trial details

NCT number
NCT02818725
Sponsor
UNICANCER
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
Start date
2010-06-01
Primary completion
2016-09-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.